NIH begins testing Ebola treatment in early-stage trial
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the NIH Clinical Center in Bethesda. The Phase 1 clinical trial is examining safety and tolerability of a single monoclonal antibody called mAb114, which was developed by scientists at NIAID. May 23, 2018